Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A4I9V4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 181 | 185 | PF00656 | 0.657 |
CLV_C14_Caspase3-7 | 188 | 192 | PF00656 | 0.790 |
CLV_C14_Caspase3-7 | 19 | 23 | PF00656 | 0.590 |
CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.681 |
CLV_NRD_NRD_1 | 123 | 125 | PF00675 | 0.529 |
CLV_NRD_NRD_1 | 28 | 30 | PF00675 | 0.548 |
CLV_PCSK_KEX2_1 | 105 | 107 | PF00082 | 0.730 |
CLV_PCSK_KEX2_1 | 123 | 125 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 28 | 30 | PF00082 | 0.548 |
CLV_PCSK_PC1ET2_1 | 105 | 107 | PF00082 | 0.540 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 55 | 59 | PF00082 | 0.620 |
CLV_PCSK_SKI1_1 | 77 | 81 | PF00082 | 0.586 |
DEG_SPOP_SBC_1 | 185 | 189 | PF00917 | 0.560 |
DEG_SPOP_SBC_1 | 245 | 249 | PF00917 | 0.552 |
DOC_CYCLIN_RxL_1 | 74 | 85 | PF00134 | 0.654 |
DOC_PP1_RVXF_1 | 75 | 82 | PF00149 | 0.562 |
DOC_PP2B_LxvP_1 | 115 | 118 | PF13499 | 0.642 |
DOC_PP2B_LxvP_1 | 99 | 102 | PF13499 | 0.696 |
DOC_PP4_FxxP_1 | 31 | 34 | PF00568 | 0.660 |
DOC_USP7_MATH_1 | 118 | 122 | PF00917 | 0.662 |
DOC_USP7_MATH_1 | 185 | 189 | PF00917 | 0.781 |
DOC_USP7_MATH_1 | 198 | 202 | PF00917 | 0.634 |
DOC_USP7_MATH_1 | 245 | 249 | PF00917 | 0.562 |
DOC_USP7_MATH_1 | 36 | 40 | PF00917 | 0.735 |
LIG_14-3-3_CanoR_1 | 132 | 136 | PF00244 | 0.614 |
LIG_14-3-3_CanoR_1 | 221 | 230 | PF00244 | 0.541 |
LIG_BIR_III_4 | 231 | 235 | PF00653 | 0.506 |
LIG_CAP-Gly_1 | 274 | 277 | PF01302 | 0.682 |
LIG_deltaCOP1_diTrp_1 | 22 | 31 | PF00928 | 0.551 |
LIG_eIF4E_1 | 15 | 21 | PF01652 | 0.495 |
LIG_eIF4E_1 | 205 | 211 | PF01652 | 0.729 |
LIG_EVH1_2 | 67 | 71 | PF00568 | 0.590 |
LIG_FHA_1 | 125 | 131 | PF00498 | 0.570 |
LIG_FHA_1 | 223 | 229 | PF00498 | 0.569 |
LIG_FHA_1 | 94 | 100 | PF00498 | 0.589 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.597 |
LIG_FHA_2 | 17 | 23 | PF00498 | 0.579 |
LIG_LIR_Apic_2 | 203 | 208 | PF02991 | 0.642 |
LIG_LIR_Nem_3 | 53 | 57 | PF02991 | 0.565 |
LIG_MYND_1 | 208 | 212 | PF01753 | 0.702 |
LIG_MYND_3 | 1 | 5 | PF01753 | 0.519 |
LIG_SH2_CRK | 205 | 209 | PF00017 | 0.610 |
LIG_SH2_CRK | 54 | 58 | PF00017 | 0.583 |
LIG_SH2_GRB2like | 109 | 112 | PF00017 | 0.689 |
LIG_SH2_SRC | 205 | 208 | PF00017 | 0.676 |
LIG_SH2_STAT5 | 109 | 112 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 167 | 170 | PF00017 | 0.597 |
LIG_SH2_STAT5 | 236 | 239 | PF00017 | 0.546 |
LIG_SH2_STAT5 | 92 | 95 | PF00017 | 0.604 |
LIG_WW_3 | 206 | 210 | PF00397 | 0.708 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.592 |
MOD_CK1_1 | 170 | 176 | PF00069 | 0.642 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.574 |
MOD_CK2_1 | 107 | 113 | PF00069 | 0.645 |
MOD_CK2_1 | 189 | 195 | PF00069 | 0.748 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.505 |
MOD_GlcNHglycan | 141 | 144 | PF01048 | 0.629 |
MOD_GlcNHglycan | 155 | 160 | PF01048 | 0.635 |
MOD_GlcNHglycan | 191 | 194 | PF01048 | 0.738 |
MOD_GlcNHglycan | 200 | 203 | PF01048 | 0.579 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.744 |
MOD_GSK3_1 | 131 | 138 | PF00069 | 0.609 |
MOD_GSK3_1 | 167 | 174 | PF00069 | 0.585 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.685 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.748 |
MOD_GSK3_1 | 222 | 229 | PF00069 | 0.545 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.586 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.433 |
MOD_GSK3_1 | 55 | 62 | PF00069 | 0.469 |
MOD_N-GLC_1 | 124 | 129 | PF02516 | 0.690 |
MOD_N-GLC_1 | 149 | 154 | PF02516 | 0.672 |
MOD_N-GLC_1 | 226 | 231 | PF02516 | 0.560 |
MOD_N-GLC_1 | 50 | 55 | PF02516 | 0.617 |
MOD_NEK2_1 | 130 | 135 | PF00069 | 0.583 |
MOD_NEK2_1 | 137 | 142 | PF00069 | 0.604 |
MOD_NEK2_1 | 171 | 176 | PF00069 | 0.620 |
MOD_NEK2_1 | 222 | 227 | PF00069 | 0.553 |
MOD_NEK2_1 | 246 | 251 | PF00069 | 0.619 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.376 |
MOD_NEK2_2 | 7 | 12 | PF00069 | 0.638 |
MOD_PIKK_1 | 246 | 252 | PF00454 | 0.675 |
MOD_PK_1 | 226 | 232 | PF00069 | 0.677 |
MOD_PKA_2 | 131 | 137 | PF00069 | 0.580 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.762 |
MOD_PKB_1 | 219 | 227 | PF00069 | 0.621 |
MOD_Plk_1 | 226 | 232 | PF00069 | 0.555 |
MOD_Plk_1 | 50 | 56 | PF00069 | 0.645 |
MOD_Plk_1 | 7 | 13 | PF00069 | 0.681 |
MOD_Plk_4 | 16 | 22 | PF00069 | 0.493 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.606 |
TRG_DiLeu_BaEn_1 | 218 | 223 | PF01217 | 0.614 |
TRG_DiLeu_BaLyEn_6 | 206 | 211 | PF01217 | 0.726 |
TRG_DiLeu_LyEn_5 | 218 | 223 | PF01217 | 0.614 |
TRG_ENDOCYTIC_2 | 54 | 57 | PF00928 | 0.553 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P396 | Leptomonas seymouri | 63% | 97% |
A0A0S4J125 | Bodo saltans | 34% | 100% |
A0A0S4J4Y9 | Bodo saltans | 34% | 100% |
A0A1X0P9Q3 | Trypanosomatidae | 39% | 100% |
A0A3Q8IH55 | Leishmania donovani | 100% | 100% |
A0A3R7LYE4 | Trypanosoma rangeli | 41% | 100% |
A4H7T2 | Leishmania braziliensis | 81% | 100% |
C9ZMS8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9B4W7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q360 | Leishmania major | 88% | 100% |
V5DJW1 | Trypanosoma cruzi | 41% | 96% |